IndiaTickerPress Release - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Company dossier
Natco Pharma
NSE:NATCOPHARM · ISIN INE987B01026
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Natco Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderBSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Natco Pharma LimitedNSE · financial results · pdf
Archived filing Natco Pharma Ltd - 524816 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Change in Management - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Retirement - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Trading Window - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Natco Pharma LimitedNSE · conference call · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Natco Pharma LimitedNSE · conference call · pdf
Source filing Copy of Newspaper Publication - Natco Pharma LimitedNSE · financial results · pdf
Source filing Natco Pharma Ltd - 524816 - Audited Financial Results For The Quarte And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing Natco Pharma Ltd - 524816 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Natco Pharma LimitedNSE · investor presentation · pdf
Source filing Outcome of Board Meeting - Natco Pharma LimitedNSE · financial results · pdf
Source filing Natco Pharma Ltd - 524816 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Natco Pharma LimitedNSE · conference call · pdf
Source filing Natco Pharma Ltd - 524816 - Board Meeting Intimation for Considering Audited Financial Results For The Financial Year Ended 31St March, 2026BSE · financial results · pdf
Source filing Natco Pharma Ltd - 524816 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
BSE · exchange filing · pdf
Source filing Action(s) initiated or orders passed - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Natco Pharma LimitedNSE · exchange filing · pdf
Source filing Natco Pharma Ltd - 524816 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing